One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials
EuroIntervention
; 12(10): 1255-1262, 2016.
Article
em En
| SES-SP, SESSP-IDPCPROD, SES-SP
| ID: biblio-1062697
Biblioteca responsável:
BR79.1
Localização: BR79.1
ABSTRACT
We sought to compare the outcomes of low/moderate complexity patients treated with the Absorb BVS from the ABSORB EXTEND trial with patients treated with the XIENCE everolimus-eluting stent (EES), using propensity score (PS) matching of pooled data from the SPIRIT trials (SPIRIT II, SPIRIT III, SPIRIT IV) and the XIENCE V USA trial...
Buscar no Google
Coleções:
06-national
/
BR
Base de dados:
SES-SP
/
SESSP-IDPCPROD
Assunto principal:
Stents
/
Serviço Hospitalar de Admissão de Pacientes
Idioma:
En
Revista:
EuroIntervention
Ano de publicação:
2016
Tipo de documento:
Article